CREBZF expression based on
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison | Statistical significance |
Normal-vs-Primary | 3.24718030242366E-12 |
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
4.67609999998952E-06 |
Normal-vs-Stage2 |
3.766500000002E-05 |
Normal-vs-Stage3 |
N/A |
Normal-vs-Stage4 |
1.560490E-03 |
Stage1-vs-Stage2 |
6.659600E-01 |
Stage1-vs-Stage3 |
N/A |
Stage1-vs-Stage4 |
6.450000E-01 |
Stage2-vs-Stage3 |
N/A |
Stage2-vs-Stage4 |
9.140400E-01 |
Stage3-vs-Stage4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
2.09639972048592E-10 |
Normal-vs-AfricanAmerican |
1.213400E-01 |
Normal-vs-Asian |
1.34179999999873E-07 |
Caucasian-vs-AfricanAmerican |
8.651800E-02 |
Caucasian-vs-Asian |
2.038400E-01 |
AfricanAmerican-vs-Asian |
3.825800E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
2.35270000004117E-06 |
Normal-vs-Female |
1.86940000146407E-08 |
Male-vs-Female |
8.812000E-02 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 1 sample.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
2.155800E-03 |
Normal-vs-Extreme_Weight |
2.98769999995674E-06 |
Normal-vs-Obese |
1.376900E-03 |
Normal-vs-Extreme_Obese |
N/A |
Normal_Weight-vs-Extreme_Weight |
3.245000E-01 |
Normal_Weight-vs-Obese |
6.432800E-01 |
Normal_Weight-vs-Extreme_Obese |
N/A |
Extreme_Weight-vs-Obese |
6.157000E-01 |
Extreme_Weight-vs-Extreme_Obese |
N/A |
Obese-vs-Extreme_Obese |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.596420E-01 |
Normal-vs-Age(41-60Yrs) |
3.609400E-04 |
Normal-vs-Age(61-80Yrs) |
1.62069999642966E-08 |
Normal-vs-Age(81-100Yrs) |
7.445800E-04 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.628600E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.200600E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.993400E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.809180E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.864200E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.833400E-01 |
|
|
CHOL : Cholangiocarcinoma
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
N/A |
Normal-vs-Grade 2 |
9.200400E-01 |
Normal-vs-Grade 3 |
8.903200E-01 |
Normal-vs-Grade 4 |
1.000000E+00 |
Grade 1-vs-Grade 2 |
N/A |
Grade 1-vs-Grade 3 |
N/A |
Grade 1-vs-Grade 4 |
N/A |
Grade 2-vs-Grade 3 |
8.895600E-01 |
Grade 2-vs-Grade 4 |
9.200400E-01 |
Grade 3-vs-Grade 4 |
8.903200E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 5 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
6.41910002929791E-09 |
Normal-vs-N1 |
9.3508001342002E-10 |
N0-vs-N1 |
2.139500E-02 |
|
|